POMELLA, SILVIA
POMELLA, SILVIA
Dipartimento di Scienze cliniche e Medicina Traslazionale
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview
2024-01-01 Ciani, L; Libonati, A; Dri, M; Pomella, S; Campanella, V; Barillari, G
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma
2024-07-08 Camero, S; Milazzo, L; Vulcano, F; Ceccarelli, F; Pontecorvi, P; Pedini, F; Rossetti, A; Scialis, E; Gerini, G; Cece, F; Pomella, S; Cassandri, M; Porrazzo, A; Romano, E; Festuccia, C; Gravina, G; Ceccarelli, S; Rota, R; Lotti, L; Midulla, F; Angeloni, A; Marchese, C; Marampon, F; Megiorni, F
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma
2026-01-01 Hebron, Ke; Odeniyide, P; Wei, Y; Gryder, Be; Barr, Fg; Casey, Dl; Chen, Ey; Crompton, Bd; Dela Cruz, Fs; Durbin, Ad; Ford, Hl; Gatz, Sa; Hatley, Me; Henssen, Ag; Hettmer, S; Houghton, Pj; Kendall, Gc; Khan, J; Lupo, Pj; Patel, Ag; Pomella, S; Rota, R; Schito, M; Schoot, Ra; Shern, Jf; Stanton, Bz; Stewart, Ea; Swindlehurst, Ca; Thomas, Cj; Vakoc, Cr; Vaseva, Av; Venkatramani, R; Wexler, Lh; Yustein, Jt; Hammond, S; Heske, Cm; Langenau, Dm; Linardic, Cm; Ignatius, Ms; Yohe, Me
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies
2024-01-01 Pomella, S; Melaiu, O; Cifaldi, L; Bei, R; Gargari, M; Campanella, V; Barillari, G
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
2020-01-01 Cassandri, M; Fioravanti, R; Pomella, S; Valente, S; Rotili, D; Del Baldo, G; De Angelis, B; Rota, R; Mai, A
Chemical genomics reveals histone deacetylases are required for core regulatory transcription
2019-01-01 Gryder, Be; Wu, L; Woldemichael, Gm; Pomella, S; Quinn, Tr; Park, Pmc; Cleveland, A; Stanton, Bz; Song, Y; Rota, R; Wiest, O; Yohe, Me; Shern, Jf; Qi, J; Khan, J
Design of First-in-Class Dual {EZH}2/{HDAC} Inhibitor: biochemical activity and biological evaluation in cancer cells
2020-01-01 Romanelli, A; Stazi, G; Fioravanti, R; Zwergel, C; Di Bello, E; Pomella, S; Perrone, C; Battistelli, C; Strippoli, R; Tripodi, M; Del Bufalo, D; Rota, R; Trisciuoglio, D; Mai, A; Valente, S
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
2023-01-31 Pomella, S; Cassandri, M; Melaiu, O; Marampon, F; Gargari, M; Campanella, V; Rota, R; Barillari, G
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma
2021-01-01 Camero, S; Vitali, G; Pontecorvi, P; Ceccarelli, S; Anastasiadou, E; Cicchetti, F; Flex, E; Pomella, S; Cassandri, M; R, R; Marampon, F; Marchese, C; Schiavetti, A; Megiorni, F
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery
2019-01-01 Chiarella, Am; Butler, Kv; Gryder, Be; Lu, D; Wang, Ta; Yu, X; Pomella, S; Khan, J; Jin, J; Hathaway, Na
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview
2024-01-01 Pomella, S; Melaiu, O; Dri, M; Martelli, M; Gargari, M; Barillari, G
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges
2024-06-14 Stanton, Bz; Pomella, S
Epigenetic remodelling in human hepatocellular carcinoma
2022-01-01 Braghini, Mr; Lo Re, O; Romito, I; Fernandez-Barrena, Mg; Barbaro, B; Pomella, S; Rota, R; Vinciguerra, M; Avila, Ma; Alisi, A
FAK Signaling in Rhabdomyosarcoma
2020-01-01 Perrone, C; Pomella, S; Cassandri, M; Rita Braghini, M; Pezzella, M; Locatelli, F; Rota, R
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas
2026-01-01 Pomella, S; Bei, R; Melaiu, O; Barillari, G
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
2021-01-01 Romito, I; Porru, M; Braghini, Mr; Pompili, L; Panera, N; Crudele, A; Gnani, D; De Stefanis, C; Scarsella, M; Pomella, S; Levi Mortera, S; de Billy, E; Conti, Al; Marzano, V; Putignani, L; Vinciguerra, M; Balsano, C; Pastore, A; Rota, R; Tartaglia, M; Leonetti, C; Alisi, A
From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment
2026-01-01 Macrì, E; Attili, M; Locatelli, F; Marampon, F; Pomella, S
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma
2023-05-18 Pomella, S; Danielli, Sg; Alaggio, R; Breunis, Wb; Hamed, E; Selfe, J; Wachtel, M; Walters, Zs; Schäfer, Bw; Rota, R; Shipley, Jm; Hettmer, S
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks
2024-08-06 Cassandri, M; Porrazzo, A; Pomella, S; Noce, B; Zwergel, C; Aiello, F; Vulcano, F; Milazzo, L; Camero, S; Pajalunga, D; Spada, M; Manzi, V; Gravina, G; Codenotti, S; Piccione, M; Tomaciello, M; Signore, M; Barillari, G; Marchese, C; Fanzani, A; De Angelis, B; Quintarelli, C; Vakoc, C; Chen, E; Megiorni, F; Locatelli, F; Valente, S; Mai, A; Rota, R; Marampon, F
Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles
2023-04-18 Pomella, S; Cassandri, M; Antoniani, F; Crotti, S; Mediani, L; Silvestri, B; Medici, M; Rota, R; Rosa, A; Carra, S
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview | Ciani, L; Libonati, A; Dri, M; Pomella, S; Campanella, V; Barillari, G | Articolo su rivista | |
| 8-lug-2024 | Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma | Camero, S; Milazzo, L; Vulcano, F; Ceccarelli, F; Pontecorvi, P; Pedini, F; Rossetti, A; Scialis, E; Gerini, G; Cece, F; Pomella, S; Cassandri, M; Porrazzo, A; Romano, E; Festuccia, C; Gravina, G; Ceccarelli, S; Rota, R; Lotti, L; Midulla, F; Angeloni, A; Marchese, C; Marampon, F; Megiorni, F | Articolo su rivista | |
| 1-gen-2026 | Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma | Hebron, Ke; Odeniyide, P; Wei, Y; Gryder, Be; Barr, Fg; Casey, Dl; Chen, Ey; Crompton, Bd; Dela Cruz, Fs; Durbin, Ad; Ford, Hl; Gatz, Sa; Hatley, Me; Henssen, Ag; Hettmer, S; Houghton, Pj; Kendall, Gc; Khan, J; Lupo, Pj; Patel, Ag; Pomella, S; Rota, R; Schito, M; Schoot, Ra; Shern, Jf; Stanton, Bz; Stewart, Ea; Swindlehurst, Ca; Thomas, Cj; Vakoc, Cr; Vaseva, Av; Venkatramani, R; Wexler, Lh; Yustein, Jt; Hammond, S; Heske, Cm; Langenau, Dm; Linardic, Cm; Ignatius, Ms; Yohe, Me | Articolo su rivista | |
| 1-gen-2024 | Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies | Pomella, S; Melaiu, O; Cifaldi, L; Bei, R; Gargari, M; Campanella, V; Barillari, G | Articolo su rivista | |
| 1-gen-2020 | CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas | Cassandri, M; Fioravanti, R; Pomella, S; Valente, S; Rotili, D; Del Baldo, G; De Angelis, B; Rota, R; Mai, A | Articolo su rivista | |
| 1-gen-2019 | Chemical genomics reveals histone deacetylases are required for core regulatory transcription | Gryder, Be; Wu, L; Woldemichael, Gm; Pomella, S; Quinn, Tr; Park, Pmc; Cleveland, A; Stanton, Bz; Song, Y; Rota, R; Wiest, O; Yohe, Me; Shern, Jf; Qi, J; Khan, J | Articolo su rivista | |
| 1-gen-2020 | Design of First-in-Class Dual {EZH}2/{HDAC} Inhibitor: biochemical activity and biological evaluation in cancer cells | Romanelli, A; Stazi, G; Fioravanti, R; Zwergel, C; Di Bello, E; Pomella, S; Perrone, C; Battistelli, C; Strippoli, R; Tripodi, M; Del Bufalo, D; Rota, R; Trisciuoglio, D; Mai, A; Valente, S | Articolo su rivista | |
| 31-gen-2023 | DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma | Pomella, S; Cassandri, M; Melaiu, O; Marampon, F; Gargari, M; Campanella, V; Rota, R; Barillari, G | Articolo su rivista | |
| 1-gen-2021 | DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma | Camero, S; Vitali, G; Pontecorvi, P; Ceccarelli, S; Anastasiadou, E; Cicchetti, F; Flex, E; Pomella, S; Cassandri, M; R, R; Marampon, F; Marchese, C; Schiavetti, A; Megiorni, F | Articolo su rivista | |
| 1-gen-2019 | Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery | Chiarella, Am; Butler, Kv; Gryder, Be; Lu, D; Wang, Ta; Yu, X; Pomella, S; Khan, J; Jin, J; Hathaway, Na | Articolo su rivista | |
| 1-gen-2024 | Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview | Pomella, S; Melaiu, O; Dri, M; Martelli, M; Gargari, M; Barillari, G | Articolo su rivista | |
| 14-giu-2024 | Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges | Stanton, Bz; Pomella, S | Articolo su rivista | |
| 1-gen-2022 | Epigenetic remodelling in human hepatocellular carcinoma | Braghini, Mr; Lo Re, O; Romito, I; Fernandez-Barrena, Mg; Barbaro, B; Pomella, S; Rota, R; Vinciguerra, M; Avila, Ma; Alisi, A | Articolo su rivista | |
| 1-gen-2020 | FAK Signaling in Rhabdomyosarcoma | Perrone, C; Pomella, S; Cassandri, M; Rita Braghini, M; Pezzella, M; Locatelli, F; Rota, R | Articolo su rivista | |
| 1-gen-2026 | Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas | Pomella, S; Bei, R; Melaiu, O; Barillari, G | Articolo su rivista | |
| 1-gen-2021 | Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects | Romito, I; Porru, M; Braghini, Mr; Pompili, L; Panera, N; Crudele, A; Gnani, D; De Stefanis, C; Scarsella, M; Pomella, S; Levi Mortera, S; de Billy, E; Conti, Al; Marzano, V; Putignani, L; Vinciguerra, M; Balsano, C; Pastore, A; Rota, R; Tartaglia, M; Leonetti, C; Alisi, A | Articolo su rivista | |
| 1-gen-2026 | From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment | Macrì, E; Attili, M; Locatelli, F; Marampon, F; Pomella, S | Articolo su rivista | |
| 18-mag-2023 | Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma | Pomella, S; Danielli, Sg; Alaggio, R; Breunis, Wb; Hamed, E; Selfe, J; Wachtel, M; Walters, Zs; Schäfer, Bw; Rota, R; Shipley, Jm; Hettmer, S | Articolo su rivista | |
| 6-ago-2024 | HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks | Cassandri, M; Porrazzo, A; Pomella, S; Noce, B; Zwergel, C; Aiello, F; Vulcano, F; Milazzo, L; Camero, S; Pajalunga, D; Spada, M; Manzi, V; Gravina, G; Codenotti, S; Piccione, M; Tomaciello, M; Signore, M; Barillari, G; Marchese, C; Fanzani, A; De Angelis, B; Quintarelli, C; Vakoc, C; Chen, E; Megiorni, F; Locatelli, F; Valente, S; Mai, A; Rota, R; Marampon, F | Articolo su rivista | |
| 18-apr-2023 | Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles | Pomella, S; Cassandri, M; Antoniani, F; Crotti, S; Mediani, L; Silvestri, B; Medici, M; Rota, R; Rosa, A; Carra, S | Articolo su rivista |